Published in Arch Neurol on May 01, 2008
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol (2010) 3.28
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation (2012) 3.12
AQP4 autoantibody assay performance in clinical laboratory service. Neurol Neuroimmunol Neuroinflamm (2014) 1.17
Aquaporin-4 autoimmunity. Neurol Neuroimmunol Neuroinflamm (2015) 1.15
Familial neuromyelitis optica. Neurology (2010) 1.14
Paraneoplastic neurological syndromes. Clin Exp Immunol (2014) 1.12
A possible paraneoplastic neuromyelitis optica associated with lung cancer. Neurol Sci (2009) 1.12
Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol (2012) 1.09
Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann Neurol (2014) 1.08
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Ann N Y Acad Sci (2015) 1.07
Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies. Int J Biochem Cell Biol (2012) 1.04
Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis. J Neurol (2013) 0.97
Anti-aquaporin-1 autoantibodies in patients with neuromyelitis optica spectrum disorders. PLoS One (2013) 0.95
The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives. Int J Mol Sci (2016) 0.93
Molecular pathogenesis of neuromyelitis optica. Int J Mol Sci (2012) 0.92
Neuromyelitis optica - an update: 2007-2009. Ann Indian Acad Neurol (2009) 0.92
Is neuromyelitis optica with advanced age of onset a paraneoplastic disorder? Int J Neurosci (2013) 0.88
Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system. J Neurol (2012) 0.87
Long extensive transverse myelitis associated with aquaporin-4 antibody and breast cancer: favorable response to cancer treatment. J Spinal Cord Med (2012) 0.83
Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4. JAMA Neurol (2014) 0.81
Paraneoplastic neuromyelitis optica associated with ANNA-1 antibodies in invasive thymoma. BMC Ophthalmol (2014) 0.77
Aquaporin-4 IgG autoimmune syndrome and immunoreactivity associated with thyroid cancer. Neurol Neuroimmunol Neuroinflamm (2016) 0.75
Screening for onconeural antibodies in neuromyelitis optica spectrum disorders. BMC Neurol (2017) 0.75
Aquaporin-4-positive myelitis associated with Sjögren syndrome and colonic adenocarcinoma. Neurol Neuroimmunol Neuroinflamm (2015) 0.75
Antibodies to aquaporin-4 in non-small cell lung cancer: a study on 50 patients. Neurol Sci (2010) 0.75
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD). Neurol Sci (2017) 0.75
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med (2002) 23.42
The spectrum of neuromyelitis optica. Lancet Neurol (2007) 11.83
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain (2007) 4.50
Brain abnormalities in neuromyelitis optica. Arch Neurol (2006) 4.28
Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol (2008) 3.95
Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc (2007) 3.32
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol (2006) 3.26
Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol (2004) 2.91
Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol (2008) 2.80
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol (2006) 2.80
Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol (2012) 2.49
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol (2013) 2.46
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology (2013) 2.34
Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol (2003) 2.29
Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med (2008) 2.26
Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol (2010) 2.26
Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci U S A (2011) 2.11
Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol (2013) 2.10
Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc (2003) 2.09
Experimental autoimmune autonomic neuropathy. J Neurophysiol (2003) 2.02
Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology (2012) 2.00
The spectrum of autoimmune autonomic neuropathies. Ann Neurol (2003) 1.93
Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc (2010) 1.85
Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol (2003) 1.79
Passive transfer of autoimmune autonomic neuropathy to mice. J Neurosci (2004) 1.78
Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol (2013) 1.78
Sleep manifestations of voltage-gated potassium channel complex autoimmunity. Arch Neurol (2011) 1.77
An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study. Lancet Neurol (2009) 1.73
Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol (2009) 1.61
Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Arch Neurol (2010) 1.60
Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Arch Neurol (2009) 1.55
Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol (2005) 1.51
Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol (2011) 1.49
Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images. Arch Neurol (2009) 1.48
Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc (2006) 1.46
Striational antibodies in a paraneoplastic context. Muscle Nerve (2013) 1.46
CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG. Neurology (2011) 1.41
Pseudopseudoseizures: conditions that may mimic psychogenic non-epileptic seizures. Psychosomatics (2011) 1.39
Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody. Arch Neurol (2004) 1.38
Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol (2002) 1.36
Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol (2012) 1.34
Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res (2004) 1.33
Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol (2010) 1.28
GABAB receptor autoantibody frequency in service serologic evaluation. Neurology (2013) 1.28
Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. Gastroenterology (2006) 1.28
Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin Gastroenterol Hepatol (2008) 1.17
Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays. J Autoimmun (2012) 1.16
NMO-IgG: a specific biomarker for neuromyelitis optica. Dis Markers (2006) 1.14
Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve (2002) 1.13
Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve (2009) 1.13
Immunotherapy-responsive dementias and encephalopathies. Continuum (Minneap Minn) (2010) 1.12
Autoimmune chorea in adults. Neurology (2013) 1.11
Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol (2012) 1.09
Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. Arch Neurol (2009) 1.08
Paraneoplastic neurological autoimmunity associated with ANNA-1 autoantibody and thymoma. Neurology (2002) 1.04
Neural autoantibody profile of primary achalasia. Dig Dis Sci (2009) 1.01
Neural antigen-specific autoimmune disorders. Immunol Rev (2012) 1.01
Eliminating false-positive results in serum tests for neuromuscular autoimmunity. Muscle Nerve (2010) 1.00
Paraneoplastic dysmotility: loss of interstitial cells of Cajal. Am J Gastroenterol (2002) 1.00
Frequency of seronegativity in adult-acquired generalized myasthenia gravis. Muscle Nerve (2007) 0.99
Neuronal voltage-gated potassium channel complex autoimmunity in children. Pediatr Neurol (2011) 0.99
Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient. Neurology (2013) 0.98
Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G. Ann Neurol (2008) 0.98
How myasthenia gravis alters the safety factor for neuromuscular transmission. J Neuroimmunol (2008) 0.97
Intractable nausea and vomiting from autoantibodies against a brain water channel. Clin Gastroenterol Hepatol (2012) 0.96
Whole-body tremulousness: isolated generalized polymyoclonus. Arch Neurol (2007) 0.91
Peripherin-IgG association with neurologic and endocrine autoimmunity. J Autoimmun (2010) 0.91
Psychiatric manifestations of voltage-gated potassium-channel complex autoimmunity. J Neuropsychiatry Clin Neurosci (2011) 0.90
Potassium channel complex autoimmunity induced by inhaled brain tissue aerosol. Ann Neurol (2012) 0.90
Neuronal ganglionic acetylcholine receptor autoimmunity. Ann N Y Acad Sci (2003) 0.87
Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. Arch Neurol (2011) 0.87
N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis. Arch Neurol (2011) 0.87
Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease. Arch Neurol (2009) 0.86
OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol (2006) 0.85
Paraneoplastic movement disorder in a patient with non-Hodgkin's lymphoma and CRMP-5 autoantibody. Mov Disord (2003) 0.84
Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study. Dig Dis Sci (2010) 0.83
Humoral pattern II multiple sclerosis pathology not associated with neuromyelitis Optica IgG. Arch Neurol (2009) 0.80
Evidence of aquaporin involvement in human central pontine myelinolysis. Acta Neuropathol Commun (2013) 0.80
Rare combination of myasthenia and motor neuronopathy, responsive to Msc-Ntf stem cell therapy. Muscle Nerve (2014) 0.79
Anti-N-methyl-D-aspartate receptor encephalitis: early treatment is beneficial. Pediatr Neurol (2010) 0.79
Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of CaV2.1 Ca2+ channel--loss-of-function cellular model of SCA6. Neurobiol Dis (2004) 0.79
ACh receptor protein drives primary and memory autoantibody responses in chimeric human-SCID mice. Clin Immunol (2002) 0.78
Autoimmune myelopathies. Continuum (Minneap Minn) (2011) 0.78
AQP4-IgG immunoprecipitation assay optimization. Clin Chem (2009) 0.78
Do calcium channel autoantibodies cause cerebellar ataxia with Lambert-Eaton syndrome? Ann Neurol (2003) 0.77
Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease. Neurology (2009) 0.76
Muscle specific kinase autoimmune myasthenia gravis in children: a case series. Neuromuscul Disord (2013) 0.76
Reversible paraneoplastic tonic pupil with PCA-Tr IgG and Hodgkin lymphoma. Neurology (2012) 0.76
Autoimmune autonomic neuropathy. An immunopharmacological disease. Clin Auton Res (2002) 0.75
Immunotherapy-responsive pain in an abattoir worker with fluctuating potassium channel-complex IgG. Neurology (2012) 0.75
Metastatic chondroblastoma with elevated creatine kinase and paraneoplastic neurologic autoimmunity. J Pediatr Hematol Oncol (2003) 0.75
Stiff eyes in stiff-person syndrome. Neurology (2009) 0.75
Paediatric autoimmune encephalopathies: a lot done, more to do. J Neurol Neurosurg Psychiatry (2012) 0.75
Muscle and neuronal autoantibody markers of thymoma: neurological correlations. Ann N Y Acad Sci (2003) 0.75
Extratemporal EEG and MRI findings in ANNA-1 (anti-Hu) encephalitis. Epilepsy Res (2011) 0.75
Asymptomatic Lambert-Eaton syndrome. Muscle Nerve (2014) 0.75